Die operative Therapie des Endometriumkarzinoms

• Literatur

• 1 Setiawan VW, Yang HP, Pike MC et al. Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol 2013; 31: 2607-2618
• 2 Brinton LA, Felix AS, McMeekin DS et al. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 2013; 129: 277-284
• 3 Levine DA, Lin O, Barakat RR et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol 2001; 80: 395-398
• 4 Segev Y, Iqbal J, Lubinski J et al. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. Gynecol Oncol 2013; 130: 127-131
• 5 Berek J, Adashi E, Hillard P. Novakʼs Gynecology. 12th ed. Baltimore: Lippincott, Williams & Wilkins; 1996
• 6 Lahti E, Blanco G, Kauppila A et al. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993; 81: 660-664
• 7 Palomba S, Falbo A, Mocciaro R et al. Laparoscopic treatment for endometrial cancer: a meta-analysis of randomized controlled trials (RCTs). Gynecol Oncol 2009; 112: 415-421
• 8 Berretta R, Merisio C, Melpignano M et al. Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population. Int J Gynecol Cancer 2008; 18: 797-802
• 9 Susini T, Massi G, Amunni G et al. Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol 2005; 96: 362-367
• 10 Mariani A, Dowdy SC, Cliby WA et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008; 109: 11-18
• 11 Abu-Rustum NR, Gomez JD, Alektiar KM et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol 2009; 115: 236-238
• 12 Todo Y, Yamamoto R, Minobe S et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol 2010; 119: 60-64
• 13 Abu-Rustum NR, Alektiar K, Iasonos A et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006; 103: 714-718
• 14 Burke WM, Orr J, Leitao M et al. SGO Clinical Practice Endometrial Cancer Working Group. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol 2014; 134: 385-392
• 15 Arbeitsgemeinschaft Gynäkologische Onkologie. Empfehlungen für die Diagnostik und Therapie des Endometriumkarzinoms. Aktualisierte Empfehlungen der Kommission Uterus auf Grundlage der S2 k Leitlinie (Version 1.0, 1.6.2008) ohne Angabe der Evidenzlevel und Empfehlungsgrade. Herausgegeben von der Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V., April 2013.. Im Internet: http://www.ago-online.de/fileadmin/downloads/leitlinien/uterus/empfehlungen_diagnostik_therapie_EC.pdf Stand: 29.01.2016
• 16 Watanabe M, Aoki Y, Kase H et al. Low risk endometrial cancer: a study of pelvic lymph node metastasis. Int J Gynecol Cancer 2003; 13: 38-41
• 17 Burke TW, Levenback C, Tornos C et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996; 62: 169-173
• 18 Todo Y, Kato H, Kaneuchi M et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375: 1165-1172
• 19 ASTEC study group. Kitchener H, Swart AM, Qian Q et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373: 125-136
• 20 Abu-Rustum NR. The increasing credibility of sentinel lymph node mapping in endometrial cancer. Ann Surg Oncol 2013; 20: 353-354
• 21 Ballester M, Naoura I, Chéreau E et al. Sentinel node biopsy upstages patients with presumed low- and intermediate-risk endometrial cancer: results of a multicenter study. Ann Surg Oncol 2013; 20: 407-412
• 22 Brucker S, Taran FA, Wallwiener D et al. Sentinel lymph node mapping in endometrial cancer: a concept ready for clinical routine?. Arch Gynecol Obstet 2014; 290: 9-11
• 23 Kim CH, Soslow RA, Park KJ et al. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 2013; 23: 964-970
• 24 Kim CH, Khoury-Collado F, Barber EL et al. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion. Gynecol Oncol 2013; 131: 714-719
• 25 Kang S, Yoo HJ, Hwang JH et al. Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol 2011; 123: 522-527
• 26 Ballester M, Dubernard G, Lécuru F et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol 2011; 12: 469-476
• 27 Ozdal B, Unlu BS, Yalcin HR et al. Role of omentectomy and appendectomy in surgical staging of endometrioid endometrial cancer. Eur J Gynaecol Oncol 2013; 34: 322-324
• 28 Sakai K, Yamagami W, Susumu N et al. Pathological factors associated with omental metastases in endometrial cancer. Eur J Gynaecol Oncol 2015; 36: 397-401
• 29 Takano M, Ochi H, Takei Y et al. Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?. Br J Cancer 2013; 109: 1760-1765
• 30 Wallwiener D, Jonat W, Kreienberg R Hrsg. Atlas der gynäkologischen Operationen. 7. Aufl. Stuttgart: Thieme; 2008
• 31 Fehm T, Taran FA, Becker S. Die operative Therapie des Endometriumkarzinoms. Frauenheilkunde up2date 2010; 4: 223-233
• 32 Rutgers JK. Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma. Future Oncol 2015; 11: 3207-3218